Moderna asks FDA to consider booster vaccine: ECDC says ‘no urgent need’ for such shots right now
Moderna has initiated its submission to the US Food and Drug Administration (FDA) to support the authorization of a booster dose of its mRNA COVID-19 vaccine at the 50-microgram (mcg) dose level.
